For example, in prostate cancer, OSMI effectively inhibits OGT‐mediated super‐enhancer‐dependent gene expression and the function of KIF1A protein, which drives neuroendocrine differentiation, thereby significantly suppressing tumor cell proliferation [393, 394]. The gene discussed is OGT; the disease is neoplasm.